144 related articles for article (PubMed ID: 38163857)
1. DNA content and clinicopathological features aid in distinguishing ameloblastic carcinoma from ameloblastoma.
Penafort PVM; Rocha AC; Mariano FV; Dos Santos JN; Oliveira MC; Vargas PA; Sperandio M
J Oral Pathol Med; 2024 Jan; 53(1):70-78. PubMed ID: 38163857
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry.
Müller S; DeRose PB; Cohen C
Arch Pathol Lab Med; 1993 Nov; 117(11):1126-31. PubMed ID: 8239934
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma.
Yoon HJ; Jo BC; Shin WJ; Cho YA; Lee JI; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Dec; 112(6):767-76. PubMed ID: 22014999
[TBL] [Abstract][Full Text] [Related]
4. Ameloblastic carcinoma developing in preexisting ameloblastoma with a mutation of the p53 gene: a case report.
Nobusawa A; Sano T; Yokoo S; Oyama T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):e146-50. PubMed ID: 24906942
[TBL] [Abstract][Full Text] [Related]
5. Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma.
Bello IO; Alanen K; Slootweg PJ; Salo T
Oral Oncol; 2009 Sep; 45(9):760-5. PubMed ID: 19150605
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of p16 tumor-suppressor gene in ameloblastic carcinoma, ameloblastoma, and dental follicles.
Khojasteh A; Khodayari A; Rahimi F; Ghaderian MH; Jafarian M; Nayebi A; Akbarzadeh Najar R; Tabatabayipanah A; Jahangirnia A
J Oral Maxillofac Surg; 2013 Jan; 71(1):62-5. PubMed ID: 22705216
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of NM23 protein in ameloblastoma and ameloblastic carcinoma: An immunohistochemical study.
Ladeji A; Olatunji S; Adebiyi K; Olajide M; Kuye O; Aborisade A
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101532. PubMed ID: 37295743
[TBL] [Abstract][Full Text] [Related]
8. Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses.
Hurník P; Putnová BM; Ševčíková T; Hrubá E; Putnová I; Škarda J; Havel M; Res O; Cvek J; Buchtová M; Štembírek J
BMC Oral Health; 2023 Aug; 23(1):563. PubMed ID: 37573343
[TBL] [Abstract][Full Text] [Related]
9. Correlation between ploidy status using flow cytometry and nucleolar organizer regions in benign and malignant epithelial odontogenic tumors.
Mohamed Mahmoud SA; El-Rouby DH; El-Ghani SF; Badawy OM
Arch Oral Biol; 2017 Jun; 78():94-99. PubMed ID: 28222389
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar organizing regions and alpha-smooth muscle actin expression in a case of ameloblastic carcinoma.
Kamath KP; Vidya M; Shetty N; Karkera BV; Jogi H
Head Neck Pathol; 2010 Jun; 4(2):157-62. PubMed ID: 20333560
[TBL] [Abstract][Full Text] [Related]
11. Ameloblastic carcinoma: a clinicopathologic analysis of cases seen in a Nigerian Teaching Hospital and review of literature.
Soyele OO; Adebiyi KE; Adesina OM; Ladeji AM; Aborisade A; Olatunji A; Adeola HA
Pan Afr Med J; 2018; 31():208. PubMed ID: 31497184
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of expression of proliferating cell nuclear antigen in variants of ameloblastoma and ameloblastic carcinoma.
Maya R; Sekar B; Murali S
Indian J Dent Res; 2012; 23(1):15-9. PubMed ID: 22842243
[TBL] [Abstract][Full Text] [Related]
13. Interrogation of TERT promoter hotspot mutations in ameloblastoma and ameloblastic carcinoma.
Magalhães MCSV; Felix FA; Guimarães LM; Dos Santos JN; de Marco LA; Gomez RS; Gomes CC; de Sousa SF
J Oral Pathol Med; 2023 Mar; 52(3):271-275. PubMed ID: 36169975
[TBL] [Abstract][Full Text] [Related]
14. Ameloblastic carcinoma, secondary type: a case report.
Karakida K; Aoki T; Sakamoto H; Takahashi M; Akamatsu T; Ogura G; Sekido Y; Ota Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e33-7. PubMed ID: 21112523
[TBL] [Abstract][Full Text] [Related]
15. IMMUNOEXPRESSION OF TWIST IN DIFFERENT MORPHOLOGICAL VARIANTS OF AMELOBLASTOMAS.
Khalil E; Rehman A; Ahmed F
J Ayub Med Coll Abbottabad; 2015; 27(2):296-303. PubMed ID: 26411101
[TBL] [Abstract][Full Text] [Related]
16. Transformation of ameloblastoma to ameloblastic carcinoma in a 10-year-old child.
Osama MA; Rao S; Kunvar S; Koul RK; Nanda BS
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147971
[TBL] [Abstract][Full Text] [Related]
17. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors.
Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I
Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730
[TBL] [Abstract][Full Text] [Related]
18. Expression of tenascin and nucleolar organizer region in ameloblastoma and ameloblastic fibroma.
Carnelio S; Vij H
J Oral Pathol Med; 2010 Mar; 39(3):223-9. PubMed ID: 19943856
[TBL] [Abstract][Full Text] [Related]
19. Primary ameloblastic carcinoma: literature review with case series.
Mahmoud SAM; Amer HW; Mohamed SI
Pol J Pathol; 2018; 69(3):243-253. PubMed ID: 30509051
[TBL] [Abstract][Full Text] [Related]
20. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology.
Brunner P; Bihl M; Jundt G; Baumhoer D; Hoeller S
Oral Oncol; 2015 Oct; 51(10):e77-8. PubMed ID: 26306423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
